EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Treatment of Primary Axillary Hyperhidrosis with Two Doses of Botulinum Toxin A—Observational Study

María Jesús Antón Andrés iD, Ernesto Domingo Candau Pérez iD, María Pilar Bermejo de la Fuente

Toxins · 2024

DOI: 10.3390/toxins16070320 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Toxins, 2024. Verfasst von María Jesús Antón Andrés und 2 weiteren Autor:innen. Beteiligte Einrichtung: Physical Medicine and Rehabilitation Service, Río Hortega University Hospital, 47012 Valladolid, Spain. Hauptthemen laut MEDLINE: Hyperhidrosis, Botulinum Toxins, Type A, Axilla, Quality of Life. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperhidrosis (HH) is defined as the production of more sweat than is necessary for its thermoregulatory function, negatively affecting patients’ quality of life and interfering with their social, work and family life. In this context, the aim of thisstudy was to evaluate the efficacy of two different doses of botulinum toxin type A (50 or 100 units) in each axilla in severe primary axillary hyperhidrosis. A descriptive, observational, cross-sectional and post-authorisation study was conducted onpatients referred to our department.Thirty-one patients with severe primary axillary hyperhidrosis were included, some of whom received more than one infiltration during the follow-up period, performing a total of 82 procedures. They were assigned by simple random sampling to two types of treatment: infiltration of 50 or 100 units (U) of botulinum toxin A per axilla.Hyperhidrosis severity was assessed using the Hyperhidrosis Disease Severity Scale (HDSS), and quality of life was assessed using the Dermatology Life Quality Index (DLQI) questionnaire. Onabotulinum toxin A infiltration reduced the severity of hyperhidrosis and improved the quality of life of the treated patients, with no significant differences between the two groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperhidrosisBotulinum Toxins, Type AAxillaQuality of LifeHumansFemaleAdultMaleCross-Sectional StudiesYoung AdultTreatment OutcomeMiddle Aged

Stichwörter der Autor:innen

axillary hyperhidrosisbotulinum toxindermatology quality of life indexhyperhidrosis severity scaleonabotulinum toxinquality of life

Substanzen

Botulinum Toxins, Type A

Autor:innen und Institutionen

  • Physical Medicine and Rehabilitation Service, Río Hortega University Hospital, 47012 Valladolid, Spain.

ORCID-Profile: María Jesús Antón Andrés, Ernesto Domingo Candau Pérez

Zitieren

APA

Antón Andrés, M. J., Candau Pérez, E. D., & Bermejo de la Fuente, M. P. (2024). Treatment of Primary Axillary Hyperhidrosis with Two Doses of Botulinum Toxin A—Observational Study. Toxins. https://doi.org/10.3390/toxins16070320

Vancouver

Antón Andrés MJ, Candau Pérez ED, Bermejo de la Fuente MP. Treatment of Primary Axillary Hyperhidrosis with Two Doses of Botulinum Toxin A—Observational Study. Toxins. 2024. doi:10.3390/toxins16070320

BibTeX
@article{AntnAndrs2024,
  author = {Antón Andrés, María Jesús and Candau Pérez, Ernesto Domingo and Bermejo de la Fuente, María Pilar},
  title = {Treatment of Primary Axillary Hyperhidrosis with Two Doses of Botulinum Toxin A—Observational Study},
  journal = {Toxins},
  year = {2024},
  doi = {10.3390/toxins16070320}
}
Kostenlos starten →